Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Medronic Acid SCHEMBL29391188 | 0.96 | SLC34A1 (0.31) | SLC34A1 | |
| Medronic Acid SCHEMBL29390548 | 0.96 | SLC34A1 (0.31) | SLC34A1 | |
| Medronic Acid SCHEMBL409013 | 0.91 | LMNA (0.35) | SLC34A1KDM4EMMP2THRBMAPK1 | |
| Medronic Acid SCHEMBL2801380 | 0.91 | SLC34A1 (0.33) | SLC34A1KDM4EMMP2THRBMAPK1 | |
| Medronic Acid SCHEMBL5423104 | 0.91 | SLC34A1 (0.33) | SLC34A1KDM4EMMP2THRBMAPK1 | |
| Medronic Acid SCHEMBL9645616 | 0.91 | SLC34A1 (0.33) | SLC34A1KDM4EMMP2THRBMAPK1 | |
| Medronic Acid SCHEMBL5267588 | 0.91 | SLC34A1 (0.43) | SLC34A1KDM4EMMP2THRBMAPK1 | |
| Medronic Acid SCHEMBL8712848 | 0.91 | SLC34A1 (0.33) | SLC34A1KDM4EMMP2THRBMAPK1 | |
| Medronic Acid SCHEMBL8712850 | 0.91 | SLC34A1 (0.33) | SLC34A1KDM4EMMP2THRBMAPK1 | |
| Medronic Acid SCHEMBL15129297 | 0.91 | SLC34A1 (0.33) | SLC34A1KDM4EMMP2THRBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117683034-A | Pyrrolo [1,2-B ] pyridazine derivatives | 吉利德科学公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-112513044-B | Pyrrolo [1,2-B ] pyridazine derivatives | 吉利德科学公司 | 2023-11-07 | — | — | CN | disclosed |
| US-20210205172-A1 | DRUG MANAGEMENT METHOD FOR KIT FORMULATION REQUIRING DOSE ADJUSTMENT | REGIMEN KIT INC (JP) | 2021-07-08 | — | — | US | disclosed |
| EP-3838246-A1 | DRUG MANAGEMENT METHOD FOR KIT FORMULATION REQUIRING DOSE ADJUSTMENT | Regimen Kit, Inc. (JP) | 2021-06-23 | — | — | EP | disclosed |
| WO-2020036231-A1 | DRUG MANAGEMENT METHOD FOR KIT FORMULATION REQUIRING DOSE ADJUSTMENT | レジメンキット株式会社 | 2020-02-20 | — | — | WO | disclosed |
| US-8674172-B2 | Prostate cancer cell lines and their use in screening method | INSTITUT GUSTAVE ROUSSY (FR) | 2014-03-18 | — | — | US | disclosed |
| US-20120036587-A1 | PROSTATE CANCER CELL LINES AND THEIR USE IN SCREENING METHOD | INSTITUT GUSTAVE ROUSSY (FR) | 2012-02-09 | — | — | US | disclosed |
| US-20100215137-A1 | Method and apparatus for producing radioisotope | JAPAN ATOMIC ENERGY AGENCY (JP) | 2010-08-26 | — | — | US | disclosed |
| CN-1802090-A | Boroproline compound combination therapy | POINT THERAPEUTICS INC (US) | 2006-07-12 | — | — | CN | disclosed |
| CN-1180841-C | Method to enhance healing of sternum after sternotomy | ������ҩ��ʽ���� | 2004-12-22 | — | — | CN | disclosed |
| CN-1382058-A | Method for promoting sternum healing after sternotomy | KAKEN PHARMA CO LTD (JP) | 2002-11-27 | — | — | CN | disclosed |